Ishares Msci Italy ETF vs 10X Genomics Inc — how do they compare? Ishares Msci Italy ETF trades at $60.32, while 10X Genomics Inc trades at $45.23 (market cap $5.81B). Which is the better fit depends on your goals.
| EWI | TXG | |
|---|---|---|
Sector | Broad Market / Factor | Health |
52-Week High | $61.14 | $45.80 |
52-Week Low | $47.75 | $11.34 |
Market Cap | — | $5.81B |
Enterprise Value | — | $5.35B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
TXG is trading at $45.80, up 9.65% today, showing strong momentum despite mixed analyst sentiment. The stock exhibits bullish technical signals with positive moving averages, though RSI levels suggest potential overbought conditions. Fundamentally, the company continues to report revenue growth with improving margins, narrowing losses from -$166M in 2022 to -$44M in 2025. Recent developments include strategic acquisitions and research collaborations that strengthen its life sciences technology position.
The outlook remains cautiously optimistic as TXG demonstrates operational improvement and strategic positioning in genomics technology. Key opportunities include continued margin expansion and platform adoption, while risks involve persistent profitability challenges and competitive pressures. Analyst consensus shows divided opinions with a $37.71 price target below current levels, suggesting potential near-term volatility despite long-term growth prospects.
Trailing returns across standard periods
Latest headlines on both assets
EWI is a country-specific ETF that tracks the performance of the Italian equity market. It provides targeted access to large and mid-sized companies in Italy, with a heavy focus on the financial sector and holdings like UniCredit and Intesa Sanpaolo.
Read more on EWI →10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →